OUR SUCCESSFUL STORY

NANOGEN BIOPHARMACEUTICAL is leading company that doing research and development of biopharmaceutical APIs, and specific therapeutic injections from recombinant DNA and protein technology in Asia Pacific region.

We are focus mainly on development of biopharmaceutical products from gene to therapy, serving high quality and innovative drug products for treatment of hepatitis B, hepatitis C, anemia due to chronic renal failure, myocardial infarction and cancer…

RECENT NEWS

The trainning of Hepatitis: Knowledge Base on Diagnosis and Treatment

APASL 2013 Singapore

06/06 đến 10/06/2013 Suntech Singapore The 23rd annual meeting of the Asian Pacific Association for the Study of the...

OUR LATEST PRODUCTS

PEGSTAT

Peginterferon alfa 2b

Prefilled syringe, Lyophilized powder, Liquid vial.

Peginterferon alfa-2b  is a covalent conjugate of recombinant alfa-2b interferon with monomethoxy...

NANERCEPT

Etanercept

Prefilled syringe, Lyophilized powder, Liquid vial.

    Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding...

Human monoclonal antibody...

Human monoclonal antibody for oncology API and Technology Transfer available:     (1) ...